FR940728-2-00113 FR940728-2-00077 Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 13, 1994, Dupont Pharmaceuticals, The Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City, New York 11530, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ‚ê£ 1Drug 1Schedule Oxycodone (9143) II Hydrocodone (9193) II Oxymorphone (9652) II Any other such applicant and any person who is presently registered with DEA top manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or request for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than (30 days from publication). Dated: July 19, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;18342 Filed 7&hyph;27&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
